Showing results (801-810 of 844) with videos related to

Sort By:
Pageof 85
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Rethinking immunologic risk: a retrospective cohort study of severe SARS-CoV-2 infections in individuals with congenital immunodeficienciesAlan A Nguyen, Saddiq B Habiballah, Brenna LaBere, et al.
Blood|September 14, 2021
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myelomaMuzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2021
Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in MassachusettsJaime E Hale, Craig D Platt, Francisco A Bonilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma studyL Khoja, E G Atenafu, S Suciu, et al.
Blood|June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisShaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Radiation and Environmental Biophysics|January 9, 2015
Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort studyL Krille, S Dreger, R Schindel, et al.
Radiology|September 25, 2019
Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and ReportingDeborah Levine, Maitray D Patel, Elizabeth J Suh-Burgmann, et al.
The Journal of Clinical Investigation|August 25, 2022
Immune dysregulation caused by homozygous mutations in CBLBErin Janssen, Zachary Peters, Mohammed F Alosaimi, et al.
Science Immunology|April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patientsThomas Condamine, George A Dominguez, Je-In Youn, et al.
Med (New York, N.Y.)|February 28, 2025
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapyJohn C Kennedy, Sara O Vargas, Martha P Fishman, et al.
Pageof 85